BioCentury
DATA GRAPHICS | Product Development

Data Bytes: Roche, Abbott pump up the volume on COVID-19 antigen tests 

September 2, 2020 10:17 PM UTC

COVID-19 antigen test launches by Roche and Abbott are poised to dramatically raise the number of rapid, point-of-care tests available per month.

On Tuesday, Roche (SIX:ROG; OTCQX:RHHBY) announced the launch of its COVID-19 antigen test in countries that accept the CE mark, and said it plans to apply for emergency use authorization (EUA) by FDA. The pharma said 40 million tests per month would be available at launch, with capacity expected to grow more than twofold by year-end...